Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV001020579 | SCV001182078 | likely benign | Hereditary cancer-predisposing syndrome | 2017-12-15 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV001069942 | SCV001235142 | likely benign | Retinoblastoma | 2024-10-02 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV001020579 | SCV002530845 | uncertain significance | Hereditary cancer-predisposing syndrome | 2021-12-16 | criteria provided, single submitter | curation | |
All of Us Research Program, |
RCV001069942 | SCV004847090 | likely benign | Retinoblastoma | 2024-09-16 | criteria provided, single submitter | clinical testing |